Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-07-11

FDA Approved: NATESTO NASAL GEL — Supplemental Application (Acerus Pharmaceuticals Corporation)

View source ↗

Summary

The FDA approved a supplemental application for NATESTO nasal gel (testosterone) submitted by Acerus Pharmaceuticals Corporation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NATESTO (testosterone)

Snippet

SUPPL AP for NATESTO NASAL GEL (TESTOSTERONE)